NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,161,408 | +0.1% | 11,402 | -0.8% | 1.31% | +7.2% |
Q2 2023 | $1,159,811 | +3.7% | 11,494 | -5.5% | 1.22% | -10.5% |
Q1 2023 | $1,118,412 | +7.7% | 12,157 | +6.2% | 1.37% | +4.7% |
Q4 2022 | $1,038,514 | +12.9% | 11,447 | -5.4% | 1.31% | -9.6% |
Q3 2022 | $920,000 | -9.9% | 12,099 | +0.1% | 1.44% | +110.0% |
Q2 2022 | $1,021,000 | -18.5% | 12,082 | -15.4% | 0.69% | +7.3% |
Q1 2022 | $1,253,000 | +0.6% | 14,276 | +0.3% | 0.64% | +16.3% |
Q4 2021 | $1,245,000 | +4.7% | 14,238 | -2.1% | 0.55% | -1.1% |
Q3 2021 | $1,189,000 | -1.6% | 14,538 | +9.8% | 0.56% | +8.8% |
Q2 2021 | $1,208,000 | 0.0% | 13,239 | -6.3% | 0.51% | 0.0% |
Q1 2021 | $1,208,000 | -9.4% | 14,132 | 0.0% | 0.51% | -10.8% |
Q4 2020 | $1,334,000 | +8.5% | 14,132 | 0.0% | 0.57% | -2.9% |
Q3 2020 | $1,229,000 | -0.4% | 14,132 | 0.0% | 0.59% | -11.4% |
Q2 2020 | $1,234,000 | +5.9% | 14,132 | 0.0% | 0.67% | -8.4% |
Q1 2020 | $1,165,000 | -14.7% | 14,132 | -1.9% | 0.73% | +16.3% |
Q4 2019 | $1,365,000 | +9.0% | 14,413 | 0.0% | 0.63% | +2.6% |
Q3 2019 | $1,252,000 | -5.2% | 14,413 | -0.3% | 0.61% | +2.3% |
Q2 2019 | $1,321,000 | -4.6% | 14,463 | +0.4% | 0.60% | +2.4% |
Q1 2019 | $1,385,000 | -44.8% | 14,407 | -50.6% | 0.58% | -7.5% |
Q4 2015 | $2,511,000 | +34.0% | 29,182 | +37.4% | 0.63% | +26.1% |
Q3 2015 | $1,874,000 | -13.8% | 21,240 | +0.0% | 0.50% | -34.8% |
Q2 2015 | $2,173,000 | -8.6% | 21,236 | -11.9% | 0.76% | -17.8% |
Q1 2015 | $2,377,000 | +3.8% | 24,104 | -2.5% | 0.93% | -1.0% |
Q4 2014 | $2,291,000 | -4.5% | 24,726 | -2.9% | 0.94% | -0.5% |
Q3 2014 | $2,398,000 | +3.9% | 25,473 | -0.1% | 0.94% | -5.4% |
Q2 2014 | $2,307,000 | -7.4% | 25,488 | -13.0% | 1.00% | -1.1% |
Q1 2014 | $2,491,000 | +6.9% | 29,301 | +1.0% | 1.01% | -1.1% |
Q4 2013 | $2,331,000 | +4.7% | 29,002 | -0.1% | 1.02% | -3.2% |
Q3 2013 | $2,227,000 | +5.1% | 29,032 | -3.1% | 1.06% | -3.7% |
Q2 2013 | $2,118,000 | – | 29,959 | – | 1.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |